22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input
16 September 2022 · A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
22 February 2022 · Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.
8 January 2020 · The below summary details the legal position regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the HMR 2012
28 April 2022 · Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.
1 March 2022 · National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines